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CD200 is a widely distributed membrane protein that gives inhibitory signals through its receptor
(CD200R) on myeloid cells. CD200 has been acquired by herpesviruses where it has been shown to
interact with host CD200R and downmodulate the immune system. It has been hypothesized that
poxviruses have acquired CD200; but the potential orthologues show less similarity to their hosts.
Myxoma virus M141 protein is a potential CD200 orthologue with a potent immune modulatory function
in rabbits. Here, we characterized the rabbit CD200, CD200R and tested the CD200-like sequences for
binding CD200R. No binding could be detected using soluble recombinant proteins, full length protein
expressed on cells or myxoma virus infected cells. Finally, using knockdown models, we showed that the
inhibitory effect of M141 on RAW 264.7 cells upon myxoma virus infection is not due to CD200R. We
conclude that the rabbit poxvirus CD200-like proteins cause immunomodulation without utilizing
CD200R.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
CD200 is a broadly distributed membrane protein that can
downregulate myeloid cell activity by interacting with an inhibi-
tory receptor termed CD200R (Hoek et al., 2000). This receptor is
only expressed on leukocytes with high levels on basophils and
macrophages (Wright et al., 2003; Shiratori et al., 2005; Akkaya
et al., 2013). A variety of herpesviruses have acquired the CD200
gene (illustrated diagrammatically in Fig. 1A) and beneﬁt from it as
a defense mechanism that downregulates the host's immune
response (Akkaya and Barclay, 2013). The CD200 orthologues from
several herpesviruses have been shown to interact with the
CD200R. These include the K14 protein from human herpesvirus 8
(HHV8 or Kaposi's Sarcoma-associated herpesvirus (KSHV))
(Shiratori et al., 2005; Foster-Cuevas et al., 2004), the Rhesus
macaque rhadinovirus (RRV) R17 protein (Langlais et al., 2006),
U85 from HHV6, and HHV7 (Shiratori et al., 2005) and the e127
protein from rat cytomegalovirus (RCMV) (Foster-Cuevas et al.,
2011). The HHV8 K14 protein (Foster-Cuevas et al., 2004) and the
RCMV e127 protein (Foster-Cuevas et al., 2011), mimic the host
protein as they have indistinguishable afﬁnities to CD200R.r Inc. This is an open access article
).
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HHV8 viral orthologues have been shown to downregulate mye-
loid activity (Shiratori et al., 2005; Foster-Cuevas et al., 2004) and
HHV8 K14 can also inhibit T cell responses (Misstear et al., 2012).
CD200-like sequences are also found in many poxviruses.
However the sequence similarity is limited and extends over a
single domain unlike host CD200 and the herpesvirus orthologues
of CD200 that contain two Ig-like domains in their extracellular
regions (Fig. 1 and Table 1). The myxoma virus CD200 orthologue
M141 can modulate the immune system but the hypothetical
interaction with CD200R has not yet been properly tested
(Cameron et al., 2005; Zhang et al., 2009). We now test whether
the M141 protein can bind rabbit (Oryctolagus cuniculus) CD200R.
O. cuniculus (European rabbit) is a host species close to the natural
hosts of the myxoma and rabbit ﬁbroma viruses, namely Sylvilagus
brasiliensis (tapeti; jungle rabbit) and Sylvilagus ﬂoridanus (eastern
cottontail) (Kerr et al., 2013; Lemos de Matos et al., 2014). While
myxoma virus causes a mild cutaneous infection in S. brasiliensis,
the infection of O. cuniculus results in a lethal systemic disease and
M141 molecule of the virus has been shown as an important
virulence factor for the development of the lethal outcome
(Cameron et al., 2005). Therefore, ﬁrstly, we identiﬁed and char-
acterized the rabbit (O. cuniculus) CD200 and CD200R and their
interaction and secondly showed that the poxvirus CD200-like
sequences, unlike the herpes CD200-like sequences, do not bind
CD200R. Furthermore, through CD200R knockdown models, we
have shown that the immune-modulatory action of the M141
molecule, shown previously in Zhang et al. (2009) is not related tounder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. (A) Cartoon illustrating the known interactions and organization of CD200 and CD200-like proteins identiﬁed in herpes- and poxviruses. Immunoglobulin (Ig)
domains are shown as ovals. CD200RL represents the activating CD200R-like proteins that associate with DAP12. Selected CD200-like proteins shown from herpesviruses are
human herpes virus 8 (HHV8) and rat cytomegalovirus (RCMV). Poxvirus CD200-like proteins shown are from lumpy skin disease virus (LSDV), rabbit ﬁbroma virus (SFV),
myxoma virus (MV) and yaba-like disease virus (YLDV). (B) Amino acid sequence alignment showing domain 1 of CD200 and CD200-like proteins from selected mammals
and herpes- and poxviruses. Mammalian CD200 proteins shown are mouse CD200 (mCD200, NP_034948), rabbit CD200 (rabCD200, BK009358), human CD200 (hCD200,
P41217) and rat CD200 (CAA25925). CD200-like proteins from RCMV and HHV8 are e127 (AAO45420) and K14 (AAK53415) respectively. Poxvirus CD200-like proteins are
YLDV 141 (NP_073526), LSDV 138 (NP_150572), MV M141 (NP_051855) and SFV 141 (NP_052027). The secondary structure of mCD200 is shown above the alignment with
arrows and squiggles indicating beta sheets and alpha helices (PDB code 4BFI, chain B). Residues at the mCD200/CD200R interaction interface are denoted by black circles
(Hatherley et al., 2013). Accession numbers are given in parentheses. Alignment generated using ESPript 3.0 server (Robert and Gouet, 2014).
Table 1
Amino acid sequence identity between domain one of CD200 from the species indicated and herpes and poxvirus CD200-like sequences. Data and abbreviations are from
analysis in Fig. 1.
SFV gp141 MV M141 LSDV 138 YLDV 141 HHV8 K14 RCMV e127 mCD200 ratCD200 rabCD200 hCD200
SFV gp141 100
MV M141 72 100
LSDV 138 39 44 100
YLDV 141 40 42 53 100
HHV8 K14 25 26 28 25 100
RCMV e127 20 22 30 29 44 100
mCD200 22 26 29 29 40 80 100
ratCD200 20 22 28 27 41 87 90 100
rabCD200 21 24 29 28 40 72 78 76 100
hCD200 24 25 28 28 41 71 79 77 84 100
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and its evolution are discussed.Fig. 3. Rabbit CD200R does not bind poxvirus M141 proteins. Surface plasmon
resonance analysis showing that rabbit CD200R (15 μM) bound to immobilised
rabbit CD200 but not to myxoma M141 or rabbit ﬁbroma virus (SFV141) proteins.
The results are typical of four experiments.Results
Identiﬁcation and analysis of rabbit CD200 and CD200R sequences
In order to be able to test whether the rabbit poxvirus CD200-
like protein interacted with host CD200R, the rabbit CD200R and
CD200 were identiﬁed from the genomic sequences for O. cuni-
culus by searching the Ensembl genome browser. The sequences of
rabbit CD200R and CD200 showed similarity to the equivalent
proteins in other mammals (e.g. 59% amino acid sequence identity
with the human CD200R and 84% for human CD200).
Recombinant soluble proteins containing the extracellular
domains for both receptor and ligand attached to a C-terminal His
tag were expressed in CHO cells, puriﬁed by Ni afﬁnity chromato-
graphy and gel ﬁltration (Fig. 2A). In addition, the extracellular
regions were expressed as chimeric proteins with ratCD4 d3þ4
(rCD4d3þ4) which is an effective and widely used antigenic tag,
together with a sequence to enable site speciﬁc biotinylation (Brown
et al., 1998). Recombinant puriﬁed rabbit CD200 and CD200R pro-
teins were sequentially passed over four ﬂow cells to which chimeric
rabbit CD200, rat CD200R, rabbit CD200R and rCD4 d3þ4 had been
bound to streptavidin coated BIAcore CM5 chips. Clear bindings of
rabbit CD200 to rabbit CD200R (and the reverse) and to rat CD200R
were observed (Fig. 2B and C). The traces showed rapid binding andFig. 2. Afﬁnity of the interaction of recombinant rabbit CD200 (Rab CD200) with rabb
proteins containing the extracellular region of rabbit CD200 and rabbit CD200R (L stan
(B) and soluble rabbit CD200R (C) binding to rabbit CD200R rCD4d3þ4, rat CD200R rCD
CD200R was passed over rabbit CD200 (D) and rabbit CD200 passed over rabbit CD200
indicated. The results are typical of three experiments.fast dissociation, typical of low afﬁnity interactions such as CD200
and CD200R (Wright et al., 2003). The afﬁnity of the rabbit CD200R/
CD200 interaction was determined by passing a range ofit CD200R (Rab CD200R). (A) Coomassie blue stained SDS PAGE showing puriﬁed
ds for protein ladder). (B–C) SPR analysis showing binding of soluble rabbit CD200
4d3þ4, rabbit CD200 rCD4d3þ4. (D–F) a range of concentrations of soluble rabbit
R (E) and rat CD200R (F) and the equilibrium coefﬁcients for each interaction are
M. Akkaya et al. / Virology 488 (2016) 1–84concentrations of the analytes sequentially over each protein and
was found to be similar irrespective of which of the two proteins
were immobilised (Kd¼ 3.3–3.4 mM) (Fig. 2D and E). These afﬁnities
were comparable to those found in other species namely Kd:1.5 mM;
0.5 mM and 4.0 mM for rat, human and mouse interactions respec-
tively (Wright et al., 2003; Foster-Cuevas et al., 2011; Hatherley et al.,
2005). The rabbit CD200 cross reacted with the rat CD200R (Fig. 2F)
and the afﬁnity (Kd:5.1 mM) was comparable to other cross species
interactions between CD200 and CD200R (Foster-Cuevas et al.,
2004). These interactions have fast dissociation rates (half life of
around a second) with a fast on-rate so equilibrium binding is
reached rapidly (see analyses (Wright et al., 2000)).
Myxoma M141 CD200-like protein does not bind rabbit CD200R
No binding of rabbit CD200R to the recombinant myxoma
M141 protein was observed by SPR (Fig. 3). The rabbit CD200R also
failed to bind another rabbit poxvirus CD200-like sequence –
rabbit ﬁbroma virus SFV 141 even though high concentrations of
recombinant proteins were used (15 mM). OX68 mAb that recog-
nizes the CD4 portion of the chimeric proteins was also passed
over the chip and bound to all four proteins giving at least 300
Response Units (RU) binding indicative of high levels of well fol-
ded chimeric protein being bound (data not shown).
To further exclude the possibility that the recombinant soluble
viral proteins do not fold properly and thus cannot bind to the
receptor, we generated cell lines that express full length viral
proteins as well as rabbit CD200 and rabbit CD200R (Fig. 4). In the
absence of speciﬁc reagents for these proteins, surface expressionsFig. 4. M141 protein is expressed at the cell surface but does not bind CD200R. (A–E) St
length sequences of rabbit CD200R (B), rabbit CD200 (C), M141 with or without N termin
beads coated with chimeric proteins containing the extracellular domains of rabbit CD2
with only rCD4 d3þ4 were used as background control. (F) Surface expression of M141 p
ﬂuorescent HA tag antibody. A stable cell line expressing M141 without HA tag was used
of three independent experiments.of rabbit CD200 and rabbit CD200R were detected using ﬂuor-
escent beads coated with rabbit CD200R and rabbit CD200
respectively by ﬂow cytometry (Fig. 4B and C). Full length M141
was expressed with a hemagglutinin tag (HA tag) at the N termi-
nus so that expression could be detected by staining the cells with
anti HA antibodies (Fig. 4F). The tag is unlikely to affect ligand
binding from analysis of the structure of the mouse CD200/
CD200R complex (Hatherley et al., 2013) but an additional cell line
expressing M141 without the HA tag was also generated. In order
to detect low afﬁnity interactions these cell lines were incubated
with ﬂuorescent beads coated with rabbit CD200R-rCD4d3þ4
chimeric proteins (except for rabbit CD200R expressing cell line
which was incubated with rabbit CD200 coated beads) or
rCD4d3þ4 coated beads as a control. Rabbit CD200R coated beads
uniformly bound to the cells that expressed rabbit CD200 but
failed to bind to any of the M141 expressing cells (Fig. 4A–E). This
provided further evidence that the M141 protein, despite being
expressed on the cell surface, does not interact with rabbit
CD200R.
Myxoma infected cells do not bind rabbit CD200R coated beads
It is possible that the failure of M141 to interact with CD200R in
both recombinant and cell surface expressing forms is due to addi-
tional viral proteins being required for binding. Therefore, we used a
cell line (RK13) that is known to produce viable myxoma virus and to
express M141 protein at the cell surface 12 h post-infection (Cameron
et al., 2005). GFP labeled wild type (WT) or M141 knock out (KO)
myxoma virus infected (0.5 moi) RK13 cells showed GFP ﬂuorescenceable 2B4 Reay cell lines transfected with mock vector (A) or vectors containing full
al hemagglutinin tag (HA tag) (D–E) were tested for binding with green ﬂuorescent
00 or rabbit CD200R together with rCD4 d3þ4 using ﬂow cytometry. Beads coated
rotein on the HA tag transfected cell line was conﬁrmed by staining the M141 with
as background control for this experiment. Flow cytometry plots are representatives
Fig. 5. Flow cytometry showing rabbit CD200R coated beads do not bind myxoma infected cells. (A) RK13 cell lines infected with GFP tagged wild type (WT vMyx GFP) or
GFP tagged M141 knock out (M141 KO vMyx GFP) virus were harvested 24 hpi. Both WT vMyx GFP (red) and M141 KO vMyx GFP (blue) infections generated comparable
numbers of virus positive cells as shown by GFP expression in ﬂow cytometry. Gray shaded area refers to uninfected cells. The gate indicates the GFP high population of the
infected cells used for the following bead binding analyses. (B) Uninfected (C) WT vMyx GFP infected and (D) M141 KO vMyx GFP infected cells were tested for binding to nile
red ﬂuorescent beads coated with biotinylated rCD4 d3þ4 chimeric proteins of rabbit CD200R (blue). Beads coated with biotinylated rCD4 d3þ4 only (gray shaded) were
used as negative control whereas, biotinylated concanavalin A coated beads were used as positive control for the bead binding assay. Flow cytometry plots are repre-
sentatives of three independent experiments.
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vious observation that knocking out M141 does not alter the growth
dynamics of the virus (Cameron et al., 2005). Uninfected RK13 cells
and WT or M141 KO virus infected cells were tested for their ability to
bind ﬂuorescent beads coated with rabbit CD200R, rCD4d3þ4
(negative control) and concanavalin A (Con A, positive control).
Although all tested cells bound the positive control Con A beads, none
bound the CD200R coated beads (Fig. 5B–D). This experiment was
repeated using different virus levels (0.1 and 1 moi) and harvesting
times (16 h and 30 h) but no binding with CD200R was observed (data
not shown).Functional effects of M141 are not mediated by host CD200R
Although the M141 protein failed to bind to CD200R in various
biochemical and cellular assays, it has been shown to have a
potent inhibitory effect on various leukocyte functions (Cameron
et al., 2005; Zhang et al., 2009). One of the most dramatic of these
effects is the differential regulation of iNOS in virus infected RAW
264.7 cells. Cells infected with M141 KO virus upregulate iNOS
expression while cells infected with WT virus fail to do so (Zhang
et al., 2009). To test whether the differences in the RAW 264.7 cell
activation upon virus infection are due to signaling through the
Fig. 6. M141 related inhibition of nitrite production in RAW264.7 cells by myxoma infection is not mediated through CD200R. (A) Knock down of mCD200R expression by
speciﬁc RNAi is shown by ﬂow cytometry after labeling cells with mCD200R mAb (OX110 and OX131). Inhibition was obtained with the knock down vector (KD) but not the
scrambled control (Scr). (B) Shows fold change in mean ﬂuorescence intensity values (MFI) for Scr and KD stable cell lines from (A) (MFI of CD200R/ MFI of isotype control)
(unpaired T test, p:0.0032; n¼3) (C) Nitrite synthesis by RAW264.7 cells stimulated by soluble IFNγ is indistinguishable in the knock down and scrambled control. (D) Plate
bound CD200R antibody gave inhibition of nitrite production in the control Scr cell line but not in KD cell line at two different concentrations of mAb (unpaired T test,
p¼0.0004 and 0.0008 respectively; n¼3). (E) Differential production of nitrite by RAW264.7 cells following infection with either WT or KO myxoma virus is unaffected by
knocking down CD200R. KD, Scr and UT cell lines were infected with wild type vMyx GFP (WT) or M141R KO vMyx GFP (KO) at 1, 2 and 4 multiplicity of infection (moi) and
nitrite assayed. The wild type virus gave effective inhibition compared to the KO virus but the effect was the same in untransfected, scrambled or CD200R knockdown
indicating that the inhibition is not dependent on the CD200R.
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erated by shRNA. The surface expression of CD200R was reduced
compared to untransfected cells (UT) and cells transfected with
control scrambled (Scr) shRNA sequence (Fig. 6A and B). The
knockdown phenotype did not alter the cells' responsiveness to
IFNγ (Fig. 6C), which was then used to test the functionality of the
knockdown phenotype. CD200R can give inhibitory signals in RAW
264.7 cells, as crosslinking CD200R using plate bound CD200R
mAb (OX131 (Akkaya et al., 2013)) gave clear inhibition of IFNγ
induced NO production but not in the CD200R knockdown line
(Fig. 6D). The possible role of CD200R in active infection by
myxoma virus was tested as in Zhang et al. (2009) where NO
production was induced by M141 KO virus but not wild type. Thisprevious result was repeated and the effect was seen irrespective
of whether the host RAW 264.7 cells were wild type, or transfected
with shRNA against CD200R or a scrambled shRNA control
(Fig. 6E). We conclude that the M141 protein acts on the innate
immune system by a mechanism other than through CD200R.Discussion
The characterization of the CD200/CD200R interaction in rabbits
indicates a similar system as found in many other species (Wright
et al., 2003; Hatherley et al., 2005, 2013; Akkaya and Barclay, 2010). It
also enabled the testing of the interactions of myxoma viral CD200-
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the previous ﬁnding that myxoma virus lacking M141 could induce
NO production in myeloid cells indicating a role in inhibiting myeloid
cell activity. Although M141 shows sequence similarity to the ligand
binding domain of CD200 (Fig. 1), we found no evidence that this
inhibitory role of M141 involved the inhibitory receptor CD200R by
various assays including direct binding, binding to transfected and
infected cells, or by knockdown of the receptor. This distinguishes
the poxvirus CD200-like protein from CD200 orthologues in her-
pesviruses where good evidence for direct binding and down reg-
ulation of cells have been obtained (Foster-Cuevas et al., 2004, 2011).
Examination of the topology of the poxvirus CD200 like proteins
(Fig. 1) and their sequences indicates that they differ more from the
host than the herpesviruses. CD200 and CD200R both have two Ig-
like domains and interact on opposing cells through their N-terminal
domains. This requires the opposing membranes to be about 14 nm
apart and consistent with many other interactions that occur at the
immunological synapse (Hatherley et al., 2013; Barclay and Brown,
2006). In contrast the poxvirus CD200-like proteins only have one
domain which would mean if they interacted with CD200R on
opposing cells, the topology – i.e. distance between the cells –might
not be optimal (see discussion of size in Hatherley et al. (2013)). In
addition the Ig-like domain shows lower sequence identity with the
host CD200 than the herpesvirus orthologues (summarized in
Table 1). The key residues involved in the interface between mouse
CD200 and mouse CD200R are indicated in Fig. 1B and it is notable
that 9 out of 17 are conserved between all the mammalian sequences
and the herpesviruses shown but only one of these residues is also
conserved in the poxvirus sequences.
The evolutionary origins of the CD200-like sequences appear
different between the herpesvirus and poxvirus CD200 like genes.
In herpesviruses the sequences are more similar to the host species
(around 40–87% see Table 1) indicating the genes have been
acquired independently. The poxvirus sequences show lower
identity with their host CD200 (around 20–30% identity) but in
contrast the Ig-like domain of M141 shows higher sequence simi-
larity to other poxviruses with around 50% amino acid sequence
identity to deerpox, sheeppox, lumpy skin disease virus and 70%
identity to rabbit ﬁbroma virus proteins. This suggests that the
poxvirus sequence may have been acquired, evolved and main-
tained by poxviruses. As the poxvirus CD200-like proteins seem
unlikely to bind CD200R, it remains a puzzle as to how they func-
tion. We suggest M141 is no longer termed CD200-like. The ﬁnding
that the rabbit myxoma product has profound cross species func-
tional effects on mouse RAW 264.7 cells (Zhang et al., 2009)
suggests it is interacting with a relatively well conserved receptor.Materials and methods
Production of recombinant proteins
The complete coding sequences of rabbit CD200 and CD200R
were identiﬁed from Ensembl database and the sequences were
submitted to the NCBI database under accession numbers
BK009358, BK009359 respectively. The sequence corresponding to
the extracellular regions (residues 1-238 for CD200R and 1-233 for
CD200) were codon-optimized, synthesized (Geneart Gene
Synthesis, Invitrogen) and cloned into pEE14 together with a
hexahistidine tag for expression in CHO-K1 cells (Hatherley et al.,
2005). These regions were also cloned into pEF-BOS for transient
expression in 293T cells as chimeric proteins with rat CD4 domains
3 and 4 (rCD4d3þ4) and a biotinylation sequence (Akkaya and
Barclay, 2013; Brown et al., 1998). Proteins used for kinetic analysis
were further puriﬁed by gel ﬁltration to ensure monomeric protein
using a Superdex 75 16/60 column (GE Life Sciences) and AKTAFPLC at 4 °C. Full length coding sequences of myxoma M141
(Accession no: NP_051855.1) and rabbit ﬁbroma virus (SFV) 141
(Accession no: NP_052027.1) were similarly codon optimized and
synthesized by Geneart Gene Synthesis. The extracellular regions
of the proteins (residues 1-178 for M141 and 1-199 for SFV 141)
were cloned into pEF-BOS vector for generation of soluble chi-
meras with rCD4d3þ4 and a biotinylation signal as
described above.
Measurement of the afﬁnity of the rabbit CD200/CD200R interaction
using surface plasmon resonance
Surface plasmon resonance experiments were performed using
a BIAcore 3000. All experiments were performed at 37 °C using
10 mM HEPES pH 7.5, 150 mM NaCl, 3 mM EDTA, 0.02% P20
(HEPES-EP) as running buffer. Concentrated tissue culture super-
natants containing biotinylated rCD4d3þ4 chimeras with the
extra cellular domains of rabbit CD200, rabbit CD200R, and rat
CD200R were immobilised to streptavidin coated ﬂow cells of a
CM5 chip (together with rCD4 d3þ4 as a negative control). Pur-
iﬁed monomeric fractions of soluble recombinant rabbit CD200 or
CD200R proteins were passed over the ﬂow cells in increasing
concentrations. Equilibrium binding was calculated by subtracting
the control binding values from the ligand-receptor binding values
and the afﬁnity calculated using Langmuir binding isotherm for-
mula and GraphPad PRISM (GraphPad Software Inc.).
Cell lines and viruses
RK13 rabbit kidney cell line, 293T human embryonic kidney cell
line, CHO-K1 chinese hamster ovary cell line and RAW 264.7 mouse
macrophage cell lines were obtained from European Collection of
Cell Cultures (Salisbury, UK). 2B4 Reay T cell hybridoma, Phoenix Eco
packaging cell line were from Marion H. Brown and as described in
Akkaya et al. (2013). All cell lines were grown in RPMI 1640 (Gibco)
media supplemented with 50 mM 2-mercaptoethanol, 50 U/ml
penicillin, 50 mM streptomycin (PAA), 2 mM L-glutamine (PAA),
0.1 mM non-essential amino acids (Sigma), 1 mM sodium pyruvate
(Sigma), 10 mM HEPES (PAA). WT vMyx GFP and M141KO vMyx GFP
viruses were gifts from Grant McFadden (University of Florida) and
were as described previously in Cameron et al. (2005) and Zhang
et al. (2009). Viral stocks for both viruses were grown and puriﬁed
using the guidelines in Smallwood et al. (2010).Bead binding to cell lines
Full length rabbit CD200, rabbit CD200R, M141R genes (with
and without 50 HA tag) were cloned into pFB-Neo retroviral
expression vector (Agilent), transfected into Phoenix Eco packa-
ging cell line using Fugene 6 (Promega) and the supernatants
containing retroviruses harvested and used to transduce the 2B4
Reay T cell line. Stable cell lines were selected with G418 and
tested for binding with green ﬂuorescent beads (Spherotech)
coated with rCDd3þ4 chimeric proteins of rabbit CD200 and
CD200R, or rCD4d3þ4 (control). Expression of HA tag conjugated
M141 molecule was tested using FITC conjugated anti-HA mAb
(Sigma).
RK13 cells were infected with either WT (WT vMyx GFP) or
M141 KO (M141 KO vMyx GFP) virus (0.5 moi). 24 h post infection
cells were harvested and tested for their binding with nile red
ﬂuorescent beads (Spherotech) coated with rCDd3þ4 chimeric
proteins of rabbit CD200R or mouse CD200R. Beads coated with
rCD4d3þ4 were used as a background control whereas beads
coated with concanavalin A (Vector Laboratories) were used as a
positive control. Dead cells were gated out by staining the cells
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metry experiments were performed using a CyAn™ ﬂow cyto-
meter (Beckman Coulter) and data analysis was performed using
Flow Jo software.mCD200R knock down
Speciﬁc shRNA against host CD200R and non speciﬁc scrambled
shRNA were generated using the following oligonucleotides
designed by the oligoengine RNAi design tool: (Scrambled forward:
50GATCCCCGAACCATATCTATACTGAATTCAAGAGATTCAGTATAGATA-
TGGTTCTTTTTC30; scrambled reverse: 50TCGAGAAAAAGAACCATA
TCTATACTGAATCTCTTGAATTCAGTATAGATATGGTTCGGG30; speciﬁc
forward: 50GATCCCCCCAAAATTAGAAGCTACTTTTCAAGAGAAAGTAG
CTTCTAATTTTGGTTTTTC30; speciﬁc reverse: 50TCGAGAAAAACCA
AAATTAGAAGCTACTTTCTCTTGAAAAGTAGCTTCTAATTTTGGGGG30).
Forward and reverse oligonucleotides for each group were mixed at
equimolar concentrations and annealed by stepwise cooling. The
annealed inserts were ligated into the pSUPERIOR Puro (Oli-
goengine) vector according to manufacturer's guidelines. Vectors
containing speciﬁc or scrambled inserts were transfected into RAW
264.7 cell line using Fugene 6 transfection reagent (Promega) and
stable colonies were generated by growing the cells in 4 μg/ml
puromycin containing media. Surface levels of CD200R on trans-
fected cells were determined by staining the cells with a mCD200R
mAb (OX110) or an isotype control.RAW 264.7 cell stimulation and Griess assay
To test the functional relevance of CD200R knock down,
transfected (scrambled and speciﬁc) RAW 264.7 cells were seeded
in 96 well plates (1.2105 live cells in 200 μl media with or
without added IFN gamma) previously coated with mCD200R
monoclonal antibody (OX131) or an isotype control antibody for
16 h. To test the effect of the possible M141/CD200R interactions
RAW 264.7 cells (transfected and untransfected) plated similarly
on uncoated 96 well plates were stimulated by infecting with
myxoma virus (WT vMyx GFP) or M141 KO (M141 KO vMyx GFP)
virus) for 16 h as previously described in Zhang et al. (2009).
Supernatants were collected and assayed for nitrite using the
Griess Reagent System (Promega).Acknowledgments
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